Orogen Royalties Incorporation

As of June 30, 2026, Orogen Royalties Incorporation carries a market capitalization of 219.64M, placing it among publicly traded companies globally. Its enterprise value stands at 189.57M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Orogen Royalties Incorporation's next confirmed earnings release is scheduled for December 1, 2026.

As of June 30, 2026, Orogen Royalties Incorporation has 59.36M shares outstanding.

As of June 30, 2026, Orogen Royalties Incorporation trades at a trailing price-to-earnings ratio of 22.34. The price-to-sales ratio is 13.33, and the price-to-book ratio stands at 5.90.

As of June 30, 2026, Orogen Royalties Incorporation trades at an EV/EBITDA multiple of 42.97 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 11.79 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 43.88 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Orogen Royalties Incorporation trades at an EV/FCF ratio of 67.98, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 189.57M versus a market cap of 219.64M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Orogen Royalties Incorporation maintains a current ratio of 23.35, meaning it holds 23.4x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Orogen Royalties Incorporation posted a return on equity (ROE) of 27.23, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.03 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 26.04, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 27.08, useful for judging operating efficiency across full business cycles. The company generates approximately 1.74M in revenue per employee across its workforce of 9.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Orogen Royalties Incorporation recorded 3.18M in income tax expense. That works out to an effective tax rate of 24.89, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 12.77M, leaving 9.59M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Orogen Royalties Incorporation's stock has gained approximately 78.10% over the past 52 weeks. The 50-day moving average sits at 4.63, while the 200-day moving average is 3.74.

Over the twelve months ended June 30, 2026, Orogen Royalties Incorporation generated 16.07M in revenue and converted that into 9.59M in net income, yielding earnings per share of 0.16. EBITDA reached 4.41M, while operating income came in at 9.56M.

As of June 30, 2026, Orogen Royalties Incorporation holds 30.23M in cash and equivalents against 156,916.00 in total debt, resulting in a net debt position of -12.88M. Total book value stands at 37.24M, with working capital of 32.90M providing operational flexibility.

Orogen Royalties Incorporation produced 2.37M in operating cash flow over the twelve months ended June 30, 2026. After subtracting 414,085.00 in capital expenditures, free cash flow totaled 2.79M - equivalent to 0.05 per share.

Over the twelve months ended June 30, 2026, Orogen Royalties Incorporation posted a gross margin of 99.43, reflecting its pricing power and cost economics. The operating margin of 59.51 and net profit margin of 59.67 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 1.27, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 3.23, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Orogen Royalties Incorporation shareholders.

Orogen Royalties Incorporation's most recent stock split took place on July 11, 2025 with a 4:1 split ratio.

As of June 30, 2026, Orogen Royalties Incorporation has an Altman Z-Score of 87.07, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.